---
figid: PMC4050248__jcbfm201451f7
figlink: /pmc/articles/PMC4050248/figure/fig7/
number: Figure 7
caption: Protein kinase C epsilon (PKCɛ) is a major regulator of mitochondrial nicotinamide
  phosphoribosyltransferase (Nampt) and nicotinamide adenine dinucleotide (NAD). Schematic
  diagram of the proposed model. (1) PKCɛ is activated after treatment with ΨɛRACK,
  resveratrol (Resv), or ischemic preconditioning (IPC) (2) and enhances the activity
  of AMP-activated protein kinase (AMPK). (3) AMPK activation leads to the induction
  of hypoxia inducible factor 1α (HIF1α) (4) which upregulates the expression of Nampt.
  (5) The anoxic conditions during IPC allow AMPK-independent induction of HIF1α and
  Nampt expression. (6) Resv can also enhance Nampt levels independent of AMPK through
  an unknown pathway. (7) PKCɛ is required for the translocation or maintenance of
  Nampt in the mitochondria. (8) Nampt converts nicotinamide (NIC) to nicotinamide
  mononucleotide (NMN). (9) The mitochondrial-specific isoform Nmnat-3 converts NMN
  to NAD+, a critical cofactor for the tricarboxylic acid (TCA) cycle, sirtuin activity,
  and poly(ADP-ribose) polymerases (PARPs).
pmcid: PMC4050248
papertitle: Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD
  following resveratrol and ischemic preconditioning in the rat cortex.
reftext: Kahlilia C Morris-Blanco, et al. J Cereb Blood Flow Metab. 2014 Jun;34(6):1024-1032.
pmc_ranked_result_index: '151214'
pathway_score: 0.9734774
filename: jcbfm201451f7.jpg
figtitle: Protein kinase C epsilon (PKCɛ) is a major regulator of mitochondrial nicotinamide
  phosphoribosyltransferase (Nampt) and nicotinamide adenine dinucleotide (NAD)
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4050248__jcbfm201451f7.html
  '@type': Dataset
  description: Protein kinase C epsilon (PKCɛ) is a major regulator of mitochondrial
    nicotinamide phosphoribosyltransferase (Nampt) and nicotinamide adenine dinucleotide
    (NAD). Schematic diagram of the proposed model. (1) PKCɛ is activated after treatment
    with ΨɛRACK, resveratrol (Resv), or ischemic preconditioning (IPC) (2) and enhances
    the activity of AMP-activated protein kinase (AMPK). (3) AMPK activation leads
    to the induction of hypoxia inducible factor 1α (HIF1α) (4) which upregulates
    the expression of Nampt. (5) The anoxic conditions during IPC allow AMPK-independent
    induction of HIF1α and Nampt expression. (6) Resv can also enhance Nampt levels
    independent of AMPK through an unknown pathway. (7) PKCɛ is required for the translocation
    or maintenance of Nampt in the mitochondria. (8) Nampt converts nicotinamide (NIC)
    to nicotinamide mononucleotide (NMN). (9) The mitochondrial-specific isoform Nmnat-3
    converts NMN to NAD+, a critical cofactor for the tricarboxylic acid (TCA) cycle,
    sirtuin activity, and poly(ADP-ribose) polymerases (PARPs).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCZ
  - PRKAG2
  - PRKCA
  - NMNAT3
  - PRKCE
  - PRKCG
  - PRKCB
  - PRKD3
  - PRKAA1
  - PRKAA2
  - PRKCH
  - PRKAG3
  - HIF1A
  - NAMPT
  - PRKCQ
  - PRKCD
  - PRKCI
  - PRKAB2
  - PRKAB1
  - PRKAG1
genes:
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Nmnat-3
  symbol: NMNAT3
  source: hgnc_symbol
  hgnc_symbol: NMNAT3
  entrez: '349565'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: HIF1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: Nampt
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: 'PKC:'
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
chemicals: []
diseases: []
---
